Although the detailed mechanisms remain unclear, this study suggested that JNK in hepatocytes may act as a tumor suppressor, whereas that in myeloid cells may act as a tumor promoter in the development of HCC. The gene discussed is MAPK8; the disease is hepatocellular carcinoma.